Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tweak API Scheme For ‘Self-Reliant’ India, Says Industry

Dr Reddy’s Considers Investment

Jul 06 2020

• By Vibha Ravi

Policies — Tweaks In India's $1.3bn Stimulus Scheme Will Make It More Viable • Source: Shutterstock

Related Content

COVID-19 Lesson: India Earmarks $1.3bn To Reduce Dependence On China

Mar 27 2020

India APIs Incentive Scheme: Will It Galvanize Local Firms, Bridle The Dragon?

Jun 08 2020

Indian Pharma Monitoring Coronavirus Fallout On Production

Feb 07 2020

India Steps Up Scrutiny After Chinese API Prices, Military Tensions Rise

Jul 03 2020

Related Companies

Dr. Reddy's Laboratories Ltd.

Sun Pharmaceutical Industries Ltd.

Torrent Pharmaceuticals Ltd.

Alembic Pharmaceuticals Limited

Cipla Limited

Mankind Pharma Ltd.

GSK plc

Additional Topics

India Asia Pacific Manufacturing Business Strategies BioPharmaceutical

More from India

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.